Live attenuated MVA monkeypox vaccine (Shanghai Institute of Biological Products)

MVA株猴痘减毒活疫苗 (上海生物制品研究所有限责任公司)

Report date: 2025/12/02 20:00:12

Base Information

Drug NameLive attenuated MVA monkeypox vaccine (Shanghai Institute of Biological Products)
Drug Alias NameMVA strain monkeypox attenuated live vaccineMonkeypox vaccine
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsMonkeypox
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Institute of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsMonkeypox
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A